Heres a look at what recent research shows can happen when you stop taking a GLP-1, plus expert tips on how to maintain the health benefits that many people reap from the medications
doi:10.3390/nu10030349 (5) Sellami, Maha, Olfa Slimeni, Andrzej Pokrywka, Goran Kuvai, Lawrence D Hayes, Mirjana Milic, y Johnny Padulo
The aim of this study was to perform an indirect treatment comparison (ITC) of the cardiovascular efficacy of tirzepatide to semaglutide in people with T2D and established CVD
doi: 10.3389/fphar.2020.00189 Received 23 September 2019 Accepted 10 February 2020 Published 04 March 2020 Volume 11 - 2020 Edited by Sabina Passamonti, University of Trieste, Italy Reviewed by Xiaoli Meng, University of Liverpool, United Kingdom
stronger real-world usability Retatrutide vs